Disposition of firocoxib in late pregnant and early postpartum mares.
Abstract: Pregnancy induces several physiologic changes that might impact the bioavailability, distribution, metabolism, and excretion of drugs. The objective of this study was to determine the effects of pregnancy on the disposition of oral firocoxib in mares. Seven pony mares received oral firocoxib paste at a dose of 0.1 mg/kg during late pregnancy and again 12 to 33 days postpartum. Firocoxib concentrations were measured in plasma by HPLC with ultraviolet detection. Maximum plasma concentrations were significantly lower in pregnant (50.0 ± 21.8 ng/mL) than in postpartum (73.7 ± 25.6 ng/mL) mares. Plasma concentrations 24 h after administration, time to maximum plasma concentrations, and area under the plasma concentration versus time curve were not significantly different between late pregnancy and the postpartum period in mares.
© 2015 John Wiley & Sons Ltd.
Publication Date: 2015-07-23 PubMed ID: 26202842DOI: 10.1111/jvp.12253Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Clinical Trial
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article investigates the effect of pregnancy on the way in which a drug called firocoxib is processed by the body, focusing specifically on late pregnant and newly postpartum mares. The study found that pregnancy did affect drug processing, with lower plasma concentrations of firocoxib observed in pregnant mares as compared to those that had just given birth.
Objectives and Study Design
- The primary goal of this study was to explore how pregnancy might influence the “disposition” – meaning the absorption, distribution, metabolism, and excretion – of a drug known as firocoxib when it’s administered to a mare orally.
- For this investigation, the researchers chose seven pony mares. These animals were given an oral paste containing 0.1 mg/kg of firocoxib, first during the later stages of pregnancy and then again 12 to 33 days after giving birth.
Methods of Analysis
- The researchers used high-performance liquid chromatography (HPLC) combined with ultraviolet detection to measure the concentration of firocoxib in the mares’ plasma. This method allowed them to characterize the drug’s disposition.
Key Findings
- The results indicated that maximum plasma concentrations of firocoxib were significantly lower in pregnant mares (averaging 50.0 ± 21.8 ng/mL) compared to postpartum mares (averaging 73.7 ± 25.6 ng/mL). This difference signifies that pregnancy does affect how firocoxib is processed in the body.
- However, the plasma concentrations of the drug 24 hours after administration, the time it took to reach maximum plasma concentrations, and the area under the plasma concentration versus time curve, were not significantly different for late stage pregnancy and postpartum periods. These findings suggest that while the highest concentration of the drug that gets into the blood (max plasma concentration) is affected by pregnancy, the overall process of drug absorption and elimination remains the same during late pregnancy and early postpartum.
Cite This Article
APA
Giguère S, Macpherson ML, Benson SM, Cox S, McNaughten JW, Pozor MA.
(2015).
Disposition of firocoxib in late pregnant and early postpartum mares.
J Vet Pharmacol Ther, 39(2), 196-198.
https://doi.org/10.1111/jvp.12253 Publication
Researcher Affiliations
- Department of Large Animal Medicine, University of Georgia, Athens, GA, USA.
- Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL, USA.
- Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL, USA.
- Department of Biomedical and Diagnostic Sciences, University of Tennessee, Knoxville, TN, USA.
- Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL, USA.
- Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL, USA.
MeSH Terms
- 4-Butyrolactone / analogs & derivatives
- 4-Butyrolactone / pharmacokinetics
- Animals
- Area Under Curve
- Cyclooxygenase 2 Inhibitors / pharmacokinetics
- Female
- Horses / metabolism
- Postpartum Period / metabolism
- Pregnancy
- Pregnancy, Animal
- Sulfones / pharmacokinetics
- Tissue Distribution
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists